MeiraGTx Holdings (MGTX) Gains from Investment Securities (2018)
MeiraGTx Holdings' (MGTX) quarterly Gains from Investment Securities came in at $2.2 million in Q2 2018, up 426.29% on a QoQ basis from -$669408.0 in Q1 2018.
Powered by 
Analysis
MeiraGTx Holdings (MGTX) Gains from Investment Securities (2018) Analysis & Trends
MeiraGTx Holdings (MGTX) has 1 years of Gains from Investment Securities data on file, last reported at $2.2 million in Q2 2018.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $2.2 million in Q2 2018, while the trailing twelve-month figure through Dec 2018 was $1.5 million (changed N/A YoY) and the FY2018 annual result came in at $1.5 million, up 225.32% from the prior year.
- Gains from Investment Securities improved to $2.2 million in Q2 2018, from -$669408.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.2 million in Q2 2018 to a low of -$669408.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn |